A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas
2016 · Journal of Ovarian Research · 60 citations
https://doi.org/10.1186/s13048-016-0224-0
R
Ritu Aneja
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
367
Papers
8.3K
Citations
54
h-index
171
i10-index
Ritu Aneja is an academic researcher from Georgia State University. The author has contributed to research in topics: Microtubule and mitosis dynamics & Cancer Genomics and Diagnostics & Breast Cancer Treatment Studies. The author has an h-index of 54, co-authored 312 publications.
ORCID: 0000-0003-4489-5320Papers by this author
worksThe molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts
2019 · Modern Pathology · 55 citations
https://doi.org/10.1038/s41379-019-0209-9
Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers
2020 · Scientific Reports · 55 citations
https://doi.org/10.1038/s41598-020-59514-1
EM011 activates a survivin-dependent apoptotic program in human non-small cell lung cancer cells
2009 · Molecular Cancer · 40 citations
https://doi.org/10.1186/1476-4598-8-93
Quadruple-negative breast cancer: novel implications for a new disease
2020 · Breast Cancer Research · 33 citations
https://doi.org/10.1186/s13058-020-01369-5
Quantitative multi-parametric evaluation of centrosome declustering drugs: centrosome amplification, mitotic phenotype, cell cycle and death
2014 · Cell Death and Disease · 29 citations
https://doi.org/10.1038/cddis.2014.164
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat